# CBD Senior Study Flyer – Realm of Caring Foundation Insights > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cbd-senior-study-flyer-geriatric-cannabis-research/ > **Published:** 2026-04-13T17:03:08-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:22:51-04:00 > **Clinical Summary:** Explore the CBD senior study flyer detailing geriatric cannabis research and drug interactions in older adults by the Realm of Caring Foundation. --- ✦ New CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic GeriatricsCbd[Clinical Research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/)Drug InteractionsSafety Why This Matters Research in older adults represents a critical knowledge gap in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/), as this population faces unique pharmacokinetic considerations and polypharmacy risks. Dedicated senior studies help establish safety profiles and dosing parameters for a demographic increasingly seeking cannabis alternatives to conventional medications. Clinical Summary The Realm of Caring Foundation is recruiting for a CBD study specifically targeting senior participants. While specific study parameters are not detailed in the available materials, dedicated geriatric [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) addresses the distinct physiological and clinical needs of older adults. This demographic often presents with altered drug metabolism, multiple comorbidities, and complex medication regimens that require specialized consideration in cannabis therapeutics. Dr. Caplan’s Take “We desperately need more geriatric-specific data in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). Seniors metabolize cannabinoids differently and face real drug interaction risks that general population studies simply don’t capture adequately.” Clinical Perspective 🧠 Clinicians should monitor for emerging data from senior-focused CBD studies, as findings may inform age-specific dosing guidelines and drug interaction protocols. When counseling older patients on CBD use, consider baseline liver function, concurrent medications, and the potential for altered pharmacokinetics compared to younger populations. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20CBD%20Senior%20Study%20Flyer%20-%20Realm%20of%20Caring%20Foundation%20%40drcaplan&url=https%3A//realmofcaring.org/wp-content/uploads/2026/03/CBD-Senior-Study-Flyer.pdf)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//realmofcaring.org/wp-content/uploads/2026/03/CBD-Senior-Study-Flyer.pdf)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20CBD%20Senior%20Study%20Flyer%20-%20Realm%20of%20Caring%20Foundation%20--%20via%20%40drcaplan.bsky.social%20https%3A//realmofcaring.org/wp-content/uploads/2026/03/CBD-Senior-Study-Flyer.pdf)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://realmofcaring.org/wp-content/uploads/2026/03/CBD-Senior-Study-Flyer.pdf](https://realmofcaring.org/wp-content/uploads/2026/03/CBD-Senior-Study-Flyer.pdf) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis research?](#What_is_the_clinical_relevance_rating_of_this_cannabis_research) - [Which patient population does this cannabis research focus on?](#Which_patient_population_does_this_cannabis_research_focus_on) - [What type of cannabis compound is being studied?](#What_type_of_cannabis_compound_is_being_studied) - [Are there concerns about drug interactions with CBD in older adults?](#Are_there_concerns_about_drug_interactions_with_CBD_in_older_adults) - [What type of study methodology was used in this research?](#What_type_of_study_methodology_was_used_in_this_research) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis research? This research has been assigned a “High Clinical Relevance” rating (#80) by CED Clinical. This indicates strong evidence or policy relevance with direct clinical implications for [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/). #### Which patient population does this cannabis research focus on? This research specifically focuses on geriatric patients, examining cannabis use in older adults. The geriatrics tag indicates this study addresses cannabis applications for elderly populations. #### What type of cannabis compound is being studied? The research focuses on CBD (cannabidiol), one of the main non-psychoactive compounds found in cannabis. CBD is increasingly being studied for its therapeutic potential across various medical conditions. #### Are there concerns about drug interactions with CBD in older adults? Yes, drug interactions are a key focus of this research, as indicated by the “Drug Interactions” tag. This is particularly important for geriatric patients who often take multiple medications that could potentially interact with CBD. #### What type of study methodology was used in this research? This appears to be [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/), suggesting it involves human subjects rather than laboratory or animal studies. Clinical research provides more direct evidence for real-world applications in [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) settings. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Seniors make up more than 25% of adult use cannabis market in Delaware](https://cedclinic.com/cannabis-drug-interactions-seniors-market-trends/) Explore how seniors are becoming a significant segment of the cannabis market, highlighting trends and implications for geriatric [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/). [Read More](https://cedclinic.com/cannabis-drug-interactions-seniors-market-trends/) [Is cannabis safe after 65? Stanford experts reveal 5 risks older adults should know](https://cedclinic.com/is-cannabis-safe-after-65-stanford-experts-reveal-5-risks-older-adults-should-know/) Stanford experts discuss important safety considerations and risks for cannabis use in adults over 65, complementing findings from senior CBD studies. [Learn More](https://cedclinic.com/is-cannabis-safe-after-65-stanford-experts-reveal-5-risks-older-adults-should-know/) [Older adults are using cannabis edibles, U of U study says – YouTube](https://cedclinic.com/older-adults-are-using-cannabis-edibles-based-on-word-of-mouth-recommendations/) A University of Utah study highlights the increasing use of [cannabis edibles](https://cedclinic.com/decarboxylating-cannabis-process-why-how/) among older adults, providing context for geriatric cannabis research. [Watch Now](https://cedclinic.com/older-adults-are-using-cannabis-edibles-based-on-word-of-mouth-recommendations/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).